Related Experiment Video

Updated: Jul 6, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?

Christian D Becker1, Joan Gil, Maria L Padilla

  • 1Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, The Mount Sinai School of Medicine, New York, NY 10029, USA. Christian.becker@mssm.edu

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|April 15, 2008
PubMed

Insights

Idiopathic pleuroparenchymal fibroelastosis is a rare lung condition characterized by pleural and subpleural fibrosis. Early diagnosis through elastic fiber stains is crucial for differentiating it from other fibrotic lung diseases.

Area of Science:

  • Pulmonology
  • Pathology

Background:

  • Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare interstitial lung disease.
  • It is characterized by fibrotic thickening of the pleura and subpleural lung parenchyma, primarily affecting the upper lobes.
  • Awareness of IPPFE is limited, leading to potential underdiagnosis and misdiagnosis.

Observation:

  • This report details two cases of IPPFE.
  • The cases highlight the importance of considering IPPFE in the differential diagnosis of patients presenting with fibrotic processes predominantly involving the pleura and subpleural regions.

Findings:

  • IPPFE involves the proliferation of elastic fibers in the pleura and subpleural parenchyma.
  • Routine elastic fiber staining in patients with upper lobe fibrosis can aid in diagnosis.
  • IPPFE can be distinguished from usual interstitial pneumonia/idiopathic pulmonary fibrosis through specific staining.

Implications:

  • Patients with IPPFE may be at increased risk for secondary spontaneous pneumothoraces and persistent postoperative bronchopleural fistulae.
  • Further research into newly diagnosed cases may reveal shared characteristics to form an etiologic hypothesis.
  • Enhanced understanding of IPPFE is necessary to develop treatments beyond supportive care and lung transplantation.

More Related Videos

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
Flail Chest-I01:24

Flail Chest-I

Overview of Flail Chest
Flail chest is a severe and potentially life-threatening condition characterized by the fracture of three or more adjacent ribs in multiple places. It is most commonly caused by direct impacts and trauma, such as motor vehicle accidents or injuries from a steering wheel impact. It can also occur due to falls in elderly individuals with osteoporosis, or assaults involving sharp objects.
Pathophysiology
The pathophysiology of flail chest is complex, involving fractures of...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...